XELLIA PHARMS APS FDA Approval ANDA 205685

ANDA 205685

XELLIA PHARMS APS

FDA Drug Application

Application #205685

Application Sponsors

ANDA 205685XELLIA PHARMS APS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 1.2GM BASE/VIAL0TOBRAMYCIN SULFATETOBRAMYCIN SULFATE

FDA Submissions

UNKNOWN; ORIG1AP2014-09-16STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

XELLIA PHARMS APS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205685
            [companyName] => XELLIA PHARMS APS
            [docInserts] => ["",""]
            [products] => [{"drugName":"TOBRAMYCIN SULFATE","activeIngredients":"TOBRAMYCIN SULFATE","strength":"EQ 1.2GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/16\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-09-16
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.